Regeneron Pharmaceuticals (REGN) Operating Margin Growth (5y) (2014 - 2026)

Regeneron Pharmaceuticals (REGN) Operating Margin Growth (5y) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Roivant Sciences 26.16 Bn 26.85 Bn 1.16 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -3,499.00
Mar 31, 2026 -2,617.00
Dec 31, 2025 -2,551.00
Sep 30, 2025 -1,856.00
Jun 30, 2025 -426.00
Mar 31, 2025 -1,876.00
Dec 31, 2024 -1,013.00
Sep 30, 2024 -1,065.00
Jun 30, 2024 1,015.00
Mar 31, 2024 -1,108.00
Dec 31, 2023 -892.00
Sep 30, 2023 -465.00
Jun 30, 2023 -651.00
Mar 31, 2023 -759.00
Dec 31, 2022 111,275.00
Sep 30, 2022 437.00
Jun 30, 2022 141.00
Mar 31, 2022 248,436.00
Dec 31, 2021 2,503.00
Sep 30, 2021 2,376.00